Triumeq 5 mg/ 60 mg/ 30 mg dispergeerbare tabletten

{
  "form": "Dispergeerbare tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/triumeq-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Lamivudine, abacavir and dolutegravir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129443",
  "excipients": [
    "AARDBEIENCRÈMESMAAKSTOF PERMASEAL PHS-132963 Givaudan",
    "ACESULFAAM KALIUM (E 950)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "IJZEROXIDE GEEL (E 172)",
    "MACROGOL",
    "MALTODEXTRINE",
    "MANNITOL (D-) (E 421)",
    "MAÏSZETMEEL, GEMODIFICEERD (MODIFICATIE ONBEKEND",
    "NATRIUMSTEARYLFUMARAAT",
    "NATRIUMZETMEELGLYCOLAAT",
    "POLYVINYLALCOHOL (E 1203)",
    "POVIDON K 30 (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "SILICIUMDIOXIDE (E 551)",
    "SUCRALOSE (E 955)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ABACAVIRSULFAAT",
    "DOLUTEGRAVIR NATRIUM",
    "LAMIVUDINE 0-WATER"
  ],
  "leaflet_url": null,
  "authorised_at": "2023/02/20",
  "procedure_number": "EMEA/H/C/002754",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/14/940",
  "additional_monitoring": "N"
}